LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Carolina Liquid Chemistries and Diazyme Enter Into Partnership

By LabMedica International staff writers
Posted on 24 Jan 2023

Carolina Liquid Chemistries, Corp. (CLC, Greensboro, NC, USA) and Diazyme Laboratories, Inc. (San Diego, CA, USA) have entered into a partnership to expand the test menu on the Diazyme DZ-Lite c270 benchtop clinical chemistry analyzer, allowing it to run both special and routine chemistries.

In comparison to using time-consuming and labor-intensive immunoassay platforms, it is more economical to run tests on clinical chemistry analyzers. The DZ-Lite c270 is an advanced benchtop clinical chemistry analyzer with a menu of FDA-cleared, moderately complex, and innovative assays made for clinical laboratories of all sizes. The compact clinical chemistry analyzer supports 1, 2, 3, and 4-part reagent assays and has a throughput of up to 270 tests per hour. The analyzer can be used in all types of clinical laboratory settings such as reference laboratories, hospitals, and physician offices with clinical labs.


Image: DZ-Lite c270 Benchtop Chemistry Analyzer (Photo courtesy of Carolina Liquid Chemistries)
Image: DZ-Lite c270 Benchtop Chemistry Analyzer (Photo courtesy of Carolina Liquid Chemistries)

Related Links:
Carolina Liquid Chemistries, Corp. 
Diazyme Laboratories, Inc


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Biochemical Analyzer
iBC 900
New
PlGF Test
Quidel Triage PlGF Test

Latest Industry News

AMP Releases Best Practice Recommendations to Guide Clinical Laboratories Offering HRD Testing
24 Jan 2023  |   Industry

Illumina Acquires SomaLogic to Accelerate Proteomics Business
24 Jan 2023  |   Industry

Qiagen and Gencurix Partner on Development of QIAcuity Digital PCR IVD Assay
24 Jan 2023  |   Industry